Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms by Histologic Type 1 Neoplasms 1 Lymphoproliferative Disorders 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Lymphatic Diseases 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Immune System Diseases 1 Carcinoma, Adenoid Cystic 1 AIDS-Related Complex 1

Interventions

Lutetium-177 1 Lutetium 1 Carboplatin 1 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Carcinoma, Adenoid Cystic × Lutetium × Clear all

NCT06199453 2025-02-10

LuRM_ACC/2023

Maria Sklodowska-Curie National Research Institute of Oncology

Phase 2 Withdrawn

Carcinoma, Adenoid Cystic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡